Eupraxia Pharmaceuticals (EPRX) Change in Cash (2023 - 2025)
Eupraxia Pharmaceuticals (EPRX) posted quarterly Change in Cash of -$8.4 million for Q4 2025, down 132.78% year-over-year from $25.7 million in Q4 2024, and down 132.78% quarter-over-quarter from $25.7 million in Q4 2024.
Eupraxia Pharmaceuticals (EPRX) Change in Cash (2023 - 2025) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has reported Change in Cash for 3 consecutive years, with -$8.4 million the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Eupraxia Pharmaceuticals | 381.11 Mn | 379.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.43 Mn |
| Dec 31, 2024 | 25.71 Mn |
| Dec 31, 2023 | -6.01 Mn |